🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 21 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 25/11/1987 | 9,48 | 9,52 | 9,44 | 9,48 | +0,14% | 0,84% | 6.119.482 |
| 24/11/1987 | 9,28 | 9,52 | 9,24 | 9,46 | +2,96% | 3,00% | 10.633.637 |
| 23/11/1987 | 9,06 | 9,20 | 9,05 | 9,19 | +0,58% | 1,61% | 7.760.650 |
| 20/11/1987 | 8,93 | 9,16 | 8,91 | 9,14 | +1,17% | 2,82% | 14.202.706 |
| 19/11/1987 | 9,05 | 9,17 | 8,94 | 9,03 | -0,37% | 2,56% | 11.405.174 |
| 18/11/1987 | 9,10 | 9,13 | 8,85 | 9,06 | +0,44% | 3,06% | 9.437.659 |
| 17/11/1987 | 9,18 | 9,20 | 9,01 | 9,03 | -2,58% | 2,02% | 9.194.314 |
| 16/11/1987 | 9,48 | 9,48 | 9,18 | 9,26 | -0,36% | 3,08% | 9.398.045 |
| 13/11/1987 | 9,53 | 9,57 | 9,28 | 9,30 | -2,57% | 3,06% | 10.958.098 |
| 12/11/1987 | 9,60 | 9,60 | 9,45 | 9,54 | +1,91% | 1,52% | 13.042.570 |
| 11/11/1987 | 9,32 | 9,41 | 9,32 | 9,36 | +1,58% | 1,00% | 7.460.712 |
| 10/11/1987 | 9,03 | 9,33 | 8,96 | 9,22 | +0,36% | 4,11% | 15.734.462 |
| 09/11/1987 | 9,25 | 9,30 | 9,12 | 9,18 | -3,21% | 2,01% | 14.493.211 |
| 06/11/1987 | 9,78 | 9,81 | 9,44 | 9,49 | -2,19% | 3,79% | 10.437.451 |
| 05/11/1987 | 9,36 | 9,81 | 9,34 | 9,70 | +3,83% | 5,03% | 15.432.638 |
| 04/11/1987 | 9,24 | 9,41 | 9,22 | 9,34 | +0,43% | 2,01% | 11.656.066 |
| 03/11/1987 | 9,30 | 9,41 | 9,18 | 9,30 | -2,77% | 2,42% | 14.996.880 |
| 02/11/1987 | 9,54 | 9,73 | 9,49 | 9,57 | -0,55% | 2,50% | 8.339.774 |
| 30/10/1987 | 10,02 | 10,07 | 9,62 | 9,62 | +1,40% | 4,50% | 20.771.150 |
| 29/10/1987 | 8,64 | 9,52 | 8,64 | 9,49 | +9,82% | 10,12% | 14.981.789 |
| 28/10/1987 | 8,24 | 9,01 | 8,24 | 8,64 | +0,93% | 9,33% | 21.506.846 |
| 27/10/1987 | 8,43 | 8,76 | 8,32 | 8,56 | +4,19% | 5,19% | 13.193.482 |
| 26/10/1987 | 8,48 | 8,49 | 8,22 | 8,22 | -4,91% | 3,20% | 15.089.314 |
| 23/10/1987 | 8,53 | 8,70 | 8,48 | 8,64 | -0,15% | 2,56% | 13.989.542 |
| 22/10/1987 | 8,75 | 8,88 | 8,43 | 8,65 | -3,40% | 5,15% | 20.916.403 |
| 21/10/1987 | 8,85 | 8,96 | 8,48 | 8,96 | +6,96% | 5,39% | 25.822.930 |
| 20/10/1987 | 8,48 | 8,96 | 7,79 | 8,38 | -1,25% | 13,75% | 31.544.381 |
| 19/10/1987 | 9,49 | 9,49 | 7,95 | 8,48 | -13,04% | 16,20% | 36.899.870 |
| 16/10/1987 | 10,23 | 10,24 | 9,38 | 9,75 | -3,28% | 8,42% | 30.512.520 |
| 15/10/1987 | 10,07 | 10,34 | 10,07 | 10,09 | -0,52% | 2,63% | 21.091.838 |